CASE-MIX ANALYSIS ACROSS PATIENT POPULATIONS AND BOUNDARIES: A REFINED CLASSIFICATION SYSTEM DESIGNED SPECIFICALLY FOR INTERNATIONAL USE

Similar documents
All-Payer Severity-Adjusted Diagnosis-Related Groups: A Uniform Method To Severity-Adjust Discharge Data

3M APR DRG Classification System. Methodology Overview

Frightening Scenario or Manageable Change? Determining the Realistic Reimbursement Impact of ICD-10 on MS-DRGs. Lori Jayne, RHIA Donna Smith, RHIA

APR DRG Data Discovery

WORKING P A P E R. Comparative Performance of the MS-DRGS and RDRGS in Explaining Variation in Cost for Medicare Hospital Discharges BARBARA O.

Hospital Discharge Data

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 2 Episodes

Readmission Analysis Using 3M Methodology

An Analysis of Medicare Payment Policy for Total Joint Arthroplasty

TECHNICAL NOTES APPENDIX SUMMER

AN INDIRECT EVALUATION OF THE NATIONAL PROGRAM OF DIABETES MELLITUS STUDY CASE OF ROMANIA

TECHNICAL NOTES APPENDIX SUMMER

The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis

REIMBURSEMENT GUIDE. Sovereign. Spinal System

UnitedHealth Premium Program Case-mix, Severity and Risk

Efficiency Methodology

Risk Mitigation in Bundled Payment

WHO INFLUENZA VACCINE RECOMMENDATION

CD Horizon Spire. CD Horizon Spire Z PHYSICIAN REIMBURSEMENT REIMBURSEMENT GUIDE. Spinal System and. Spinal System

Enhancing the Reliability of Physician Performance on Hospital Outcome Measures

Value of Hospice Benefit to Medicaid Programs

Integrated Care Models That Work for Frail Older People

Symmetry Episode Treatment Groups

UnitedHealth Premium Program Case-mix Adjusted Benchmarks with Severity or Risk Adjustment

UnitedHealth Premium Designation Program Case-mix Adjusted Benchmarks with Severity or Risk Adjustment

Proprietary Acute Care Indicators

IMPACT OF NATIONAL INFLUENZA VACCINE CAMPAIGN ON RESPIRATORY ILLNESS IN THAILAND,

Potentially Preventable Hospitalizations in Pennsylvania

Get the Right Reimbursement for High Risk Patients

Performance Analysis:

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 5 Episodes

Diagnoses and Health Care Utilization of Children Who Are in Foster Care and Covered by Medicaid

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes

Millennium Collaborative Care PPS Community Profile

3/20/2013. "ICD-10 Update Understanding and Analyzing GEMs" March 10, 2013

More than 1.8 million New York State residents have diabetes, 1

Health for Humanity 2020 Goals 2

Integration of Oral Health Diagnostic Codes in Safety Net Dental Programs. October 25, 2011

NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES

Lowering epilepsy-related treatment costs in the era of patient choice and value-based care

Real World Patients: The Intersection of Real World Evidence and Episode of Care Analytics

Ex post evaluation Tanzania

Tutorial Copyright ACT Consult. All Rights Reserved

Using A Quality Improvement Program to Reduce Length of Stay and Readmissions: Real World Evidence from One Health Care System

What ASMBS Members Need to Know About: New Medicare Payment Policy Governing Bariatric Surgery and Hospital Acquired Conditions (HACs)

Inpatient ICD-9-CM Mapping to ICD-10 PCS Procedures Involving the Application of Integra Bilayer Wound Matrix

Discharge Abstract Database (DAD)/ CMG/Plx Data Quality. Re-abstraction Study

Massachusetts Medicaid pediatric high-risk asthma bundled payment pilot

Objectives. Medicare Spending per Beneficiary: Analyzing MSPB Data to Identify Primary Drivers

Should buprenorphine be covered for maintenance treatment in opioid dependent persons?

NCHA Financial Feature

Performance Dashboard for the Substance Abuse Treatment System in Los Angeles

Your passport to Muslim-majority countries

Global Zinc Chemicals Market Study ( )

OXYGEN IS ESSENTIAL: A POLICY BRIEF

Using APR-DRG DataVision Reports for Hospital Ranking and Physician Review

Best Doctors Service Card. Connecting Canadians to the world s best medical information

July, Years α : 7.7 / 10, Years α : 11 / 10,000 < 5 Years: 80 / 10, Reduce emergency department visits for asthma.

extraction can take place. Another problem is that the treatment for chronic diseases is sequential based upon the progression of the disease.

SADAG submission to the Competition Commission: Market Inquiry into the Private Healthcare Sector

A simple solution for your complex patients

Epidemiology of Asthma. In Wayne County, Michigan

The power of innovation to save lives

WASHINGTON perspectives

Quality Improvement through HIT

Putting the Patient First: How Advocate Healthcare Reduced Readmissions, LOS and Costs Through an Integrated Nutrition Care Process

WITH. The Next Step in Office MRI

TB epidemic and progress towards the Millennium Development Goals

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes

Policy Brief June 2014

The Interpreting Marketplace

Quality Management System Certification. Understanding Quality Management System (QMS) certification

THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability

Low Tolerance Long Duration (LTLD) Stroke Demonstration Project

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

ATS 2013 International Conference May Philadelphia Pennsylvania

The Hospital for Sick Children Technology Assessment at SickKids (TASK) FULL REPORT

Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010

2018 Cerebrovascular Reimbursement Coding Fact Sheet

Economic aspects of viral hepatitis and liver disease in Portugal

Achieving Quality and Value in Chronic Care Management

For personal use only

Quad Cities July 3, 2008

Global Polybutylene Terephthalate (PBT) Market Study ( )

Elekta Synergy Digital accelerator for advanced IGRT

New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries

Commissioning for Better Outcomes in COPD

Case mix and charges for inpatient and outpatient chemotherapy

Determining MS-DRGs. Kimberly Cunningham CPC, CIC, CCS. Copyright/Disclaimer text

Proton Therapy Market Outlook - Global Analysis

Medication Therapy Management Solution

Fiscal Year (FY) 2019 Hospital Inpatient Proposed Rule Interventional Cardiology, Peripheral Interventions & Rhythm Management

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Pulmonary

[AHIMA has developed this summary to assist the healthcare industry in beginning the transition to ICD-10-CM and ICD-10- PCS.]

Drug Overdose Morbidity and Mortality in Kentucky,

Leveraging Analytics to Mitigate Financial Risks in ICD-10

Accelero Identifies Opportunities to Provide Greater Value in Hip Fracture Care

Alex Azar Secretary, Department of Health and Human Services

Transcription:

CASE-MIX ANALYSIS ACROSS PATIENT POPULATIONS AND BOUNDARIES: A REFINED CLASSIFICATION SYSTEM DESIGNED SPECIFICALLY FOR INTERNATIONAL USE A WHITE PAPER BY: ROBERT MULLIN, MD JAMES VERTREES, PHD RICHARD FREEDMAN, PHD RUSS CASTIONI ANN TINKER, RN, MN ABSTRACT This paper describes the structure and features of the 3M International Refined-DRGs (IR-DRGs) and assesses the validity of a new approach to standardizing hospital product definitions. The clinical researchers at 3M Health Information Systems recognized that countries have these conflicting needs: A patient classification system that is unique to the country The ability to compare one country to another Building on twenty years of experience in developing classification systems, 3M has designed the new IR-DRGs to provide the same results in classifying patients regardless of the coding system used. The new system allows a country to utilize IR-DRGs using its own diagnosis and procedure codes. Furthermore, the IR-DRGs refine the DRG system using the concept of severity adjustment to better describe relative resource consumption based on individual patient characteristics.

The worldwide information revolution has catalyzed improvements to hospital data systems using case-mix analysis for decision support in resource utilization and healthcare funding arrangements. Essential to this effort is the use of a sophisticated system for classifying and evaluating complex healthcare information. Healthcare decision-makers require a means of making relative comparisons of the resources patients consume and their associated clinical courses. A single patient classification system that encompasses a wide variety of coding systems and clinical practices allows accurate bench-marking and utilization assessment, in addition to providing an accurate basis for healthcare funding and budgeting. 1 Mullin, R. Utilization Review Based on Practitioner Profiles. Journal of Medical Systems. 1983; 7(5): 409 412. Significant shifts in the management of healthcare delivery are occurring around the world. There is an increasing number of non-government-owned delivery systems involved in providing health care to populations that were either previously managed by or excluded from government-funded national health programs. Economic pressures are forcing all of these delivery models to describe, in a uniform fashion, resource utilization and outcome patterns to better manage these resources while measuring improvements in quality of care. 1 As more governments and other entities are asked to make decisions regarding the provision of health care, there comes an increased need for healthcare information and the realization of the importance of developing appropriate, common measures of hospital activity to fully utilize Diagnosis Related Groups (DRGs) or other classification systems. An appropriate system that is relevant to a country s specific needs is required to categorize the patients these healthcare systems manage. Issues A statistically valid and clinically coherent system must be employed to aggregate patient treatment episodes that are similar in their resource consumption and to explain variations in resource use. Classification systems developed for the United States and other countries can be difficult to adapt where the coding systems vary from the coding systems used in the development of the systems. It is apparent that such systems are limited in their ability to fully meet the needs of other countries. Presently, numerous coding and classification systems are used worldwide. Many countries have adopted the World Health Organization s International Classification of Diseases 10th revision (WHO ICD-10). Many countries have also developed or modified their existing procedure coding systems. 2 Averill R, Muldoon J, Vertrees J, Goldfield N, Mullin R, Fineran E, Zhang M, Steinbeck B, Grant T. The Evolution of Case-mix Measurement Using Diagnosis Related Groups. 3M Health Information Systems Research Report, May, 1998. To facilitate intra-country and across-country profiling of patterns and costs of treatment, an inpatient classification system should reflect utilization and local clinical practice patterns for all patients treated. The Centers for Medicare and Medicaid Services (formerly Health Care Financing Administration, or HCFA) DRG system reflects the utilization of services and clinical practice patterns in the care of elderly patients in U.S. hospitals. This system is inadequate as a classification scheme for assessing patterns and service costs of services incurred in treating non-medicare patients. 2 2 3M Health Information Systems Case-mix analysis across patient populations and boundaries:

All Patient-DRGs (AP-DRGs) were developed to classify the non-medicare population. AP-DRGs created additional DRG categories for neonates, pediatric patients, and patients with Human Immunodeficiency Virus (HIV). Further refinements to the AP-DRG system included the addition of the concept of Major Complications and Comorbidities (MCC). Although they have been adapted for use in other countries, the AP-DRGs were originally designed to classify the non-elderly population in New York state in the United States. Country-specific requirements and worldwide advances in healthcare technologies have created the demand for new and more refined generations of DRGs. Given the shortage of patient-specific, coded data from many countries that are required to build these systems, it was necessary to adapt classification systems primarily developed for use in the United States and other countries. A number of countries have since made significant investments in collecting patient-specific data, using coding systems such as ICD-9, ICD-9-CM, or ICD-10 for diagnosis coding, some with minor modifications for use in their country. However, a common procedure coding system is still not widely used, so countries continue to adapt existing systems or develop country-specific procedure codes. As the use of various coding systems increases, patients who exhibit similar clinical and resource consumption characteristics regardless of the country they are treated in need to be classified in a uniform and consistent way. As a result of the increased availability of reliable data, the information derived from the data needed to develop an international classification system has reached a point of quantity and quality that allows this goal to be achieved. However, numerous problems occur when a system originally developed for one country is adapted for another country where a different coding system is used. Ideally, a single classification system specifically designed for use with these various coding systems could solve these problems. As countries continue to shift from ICD-9 to ICD-10, the ideal classification system would also group a patient into the same DRG regardless of the coding system used. This would make the process of change much easier for hospital managers. Answers IR-DRGs build upon key design advancements of both the AP-DRGs and the All Patient Refined DRGs (APR-DRGs). IR-DRGs were designed not only for use as part of a funding system, but also for budgeting, outcomes analysis, benchmarking, profiling, and utilization assessment. In addition, IR-DRGs can compare resource usage across facilities and regions and support local and national health system management. IR-DRGs incorporate the concept of severity adjustment through the use of multiple levels of Complications and Comorbid conditions (CCs) applied to all base patient groups. This concept of refinement in DRG systems is not new. Refined DRGs were first developed in the United States. The term severity adjustment refers to adjustments to the base DRGs that enhance their ability to explain the resources A refined classification system designed specifically for international use 3

required to treat patients in a particular DRG. Although these DRGs perform well when applied to United States data and the ICD-9-CM coding system they were designed for, they are difficult to adapt for use in other countries where different coding systems or variations are used. The advanced sophistication of these systems within the confines of the ICD-9-CM coding system and their ability to include refinements make them flexible yet difficult to use across other coding systems. Code mapping is often used to compensate for the differences, but this approach often leads to records that are incorrectly grouped. Such errors occur because mapping itself cannot correct for the dilemma of the one-to-many, many-to-one, many-to-many, and one-to-none relationships that are encountered in mapping different or modified systems. Including severity adjustment in DRGs is a very important characteristic that enhances the clinician s ability to use DRGs as a communication tool. Therefore, the IR-DRGs incorporate explicit severity adjustment as an integral part of their design. IR-DRGs are designed to conform to ICD-10, ICD-9-CM, and ICD-9 as well as accommodate country-specific modifications and procedure coding systems. The Refined DRGs (R-DRGs), AP-DRGs, APR-DRGs, and IR-DRGs are the only DRG systems that uniformly adjust for severity across all patients. Details As a new generation of classification system, the IR-DRGs are distinguished by the fact that they were designed specifically for not adapted to suit international health care. IR-DRGs were not designed for use in the United States. Specifically, several large data sets were used to develop and subsequently test IR-DRGs. The two base data sets consisted of 6.9 million inpatient records each from the United States. However, the groups were finalized using a European database containing 200,323 records from three countries. The following list summarizes the source and number of cases contained in this database. Country Cases United States 13,800,000 Belgium 32,214 Italy 121,826 Spain 46,283 Using the same logic as AP-DRGs and APR-DRGs, IR-DRGs have three severity subclass levels (1, 2, and 3) for most DRG assignments, based on the presence and severity of Complications and Comorbid conditions (without CC, with CC, and with Major CC). These levels denote patient resource consumption. The severity level subclass assignment of secondary diagnoses was accomplished by analyzing the effects of each possible secondary diagnosis on the resource usage and assigning one of three levels to each diagnosis. Recognizing that currently most international data sets contain an average of less than two secondary diagnoses, the IR-DRGs do not use multiple CCs to assign the severity level. This system allows improved intra- and cross-country comparisons and case-mix analysis. 4 3M Health Information Systems Case-mix analysis across patient populations and boundaries:

Customization An international inpatient classification system should not only encompass a range of coding systems, it should also simplify modification of the system for country-specific requirements. It is also important for the system to accommodate customization as required by various countries while maintaining a level of consistency across countries. The integrity of the base DRGs that are the foundation of the new system permits comparability across countries. However, variations can be made to suit various international and national procedure coding customs and standards. Construction and validation The IR-DRGs consist of 319 base DRGs, 301 base DRGs with three subclass severity levels, nine base DRGs with no subclasses, three non-related operating room (OR) base DRGs with 3 subclasses, plus two error IR-DRGs with no subclasses for a total of 923 DRGs. Several base DRGs that were eliminated from the United States versions of DRGs (because these procedures were being performed in ambulatory care facilities rather than acute care hospitals) were returned to the IR-DRGs. For example, Carpal Tunnel Release, not included in the current U.S.-based systems, was incorporated into IR-DRGs because this procedure is so frequently documented as an inpatient procedure in international patient records. Previous experience with AP-DRG international groupers made it obvious that the ICD-10 coding system would require changes in the base DRGs dependent on specific ICD-9-CM codes not available in ICD-10. Thus, IR-DRGs were modified to be compatible with both ICD-9-CM and ICD-10. This resulted in a system that assures a given patient will fall in the same IR-DRG regardless of the coding system used. Each coding-system-specific version of IR-DRGs is a native grouper in which the grouper logic is expressed directly in terms of the specific diagnosis and procedure coding system used by the individual country. No mapping between coding systems is used. Using native codes to construct DRG definitions provides more coherent groupings. Performance Resource utilization varies monotonically across the severity levels in each IR-DRG. This monotonic progression is consistent across all base DRG severity levels for charges and Length of Stay (LOS) in the United States databases and in the European databases for Length of Stay (LOS) in all base DRGs with a significant number of cases. Figure 1 (next page) shows an example of this monotonic progression with a sampling of DRGs in MDC 4. The IR-DRGs show improved performance for case-mix analysis when compared to both the CMS (formerly HCFA) DRGs and the AP-DRGs. Although they continue the evolution of the AP-DRGs, the IR-DRGs are clearly better suited for international use and better able to address the challenges of the international market. A refined classification system designed specifically for international use 5

U.S. Severity Level 1 Severity Level 2 Severity Level 3 IR-DRG MDC Description TotChg1 count1 TotChg2 count2 TotChg3 count3 0436 4 Simple Pneumonia $4,953 26917 $7,460 42920 $11,920 47796 0437 4 Chronic Obstructive Pulmonary Disease $6,582 23748 $8,127 27543 $11,993 25606 0438 4 Asthma and Bronchiolitis $4,261 35059 $5,649 18042 $ 9,938 4897 0439 4 Interstitial Lung Disease $6,502 451 $8,627 1247 $13,013 1980 0440 4 Pneumothorax and Pleural Effusion $5,776 3337 $8,202 4418 $13,065 5011 Europe IR-DRG MDC Description alos1 count1 alos2 count2 alos3 count3 0436 4 Simple Pneumonia 9.03 1001 12.93 926 16.18 668 0437 4 Chronic Obstructive Pulmonary Disease 9.50 1127 12.46 915 16.46 1021 0438 4 Asthma and Bronchiolitis 5.87 608 9.41 177 14.30 69 0439 4 Interstitial Lung Disease 9.80 91 12.72 71 16.46 65 0440 4 Pneumothorax and Pleural Effusion 9.38 296 13.28 126 15.37 76 Figure 1. Summary data by severity level for medical respiratory IR-DRGs using U.S. and international data (charges are shown in U.S. dollars) Conclusion Reviewing the evolution and relevance of this new International Refined-DRG (IR-DRG) system demonstrates why existing approaches to comparing episodes of inpatient hospitalization are neither consistent nor predictive of resource use. Existing approaches can be replaced by a system designed specifically for international use that can also provide clinicians and healthcare managers with objective and reliable ways of measuring the severity and resource utilization of hospitalized patients worldwide. 3 Health Information Systems www.3m.com Asia/Pacific Canada Europe Latin America and South Africa Leon Paff Jim Stewart Anne Boucher Russ Castioni Tel: 61 2987 56219 Tel: 800 561 5115 ext. 3828 Tel: 49 2131 144244 Tel: 301 476 7005 Fax: 61 2987 56219 Fax: 905 602 6275 Fax: 49 2131 144330 Fax: 301 476 7001 International (USA) Rich A. Sanders Phone: 801 265 4814 Fax: 801 263 3658 Published September 2002. Copyright 2000 2002, 3M. All rights reserved. 3M is a trademark of 3M Company. The International Statistical Classification of Diseases and Related Health Problems - Tenth Revision (ICD-10) is copyright ed by the World Health Organization, Geneva, Switzerland, 1992-1999.